BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sarkar A, Rawat N, Sachan N, Singh MP. Unequivocal Biomarker for Parkinson’s Disease: A Hunt that Remains a Pester. Neurotox Res 2019;36:627-44. [DOI: 10.1007/s12640-019-00080-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Faizan M, Sarkar A, Singh MP. Type 2 diabetes mellitus augments Parkinson's disease risk or the other way around: facts, challenges and future possibilities. Ageing Res Rev 2022;:101727. [PMID: 36038113 DOI: 10.1016/j.arr.2022.101727] [Reference Citation Analysis]
2 Chung CC, Chan L, Chen JH, Bamodu OA, Chiu HW, Hong CT. Plasma extracellular vesicles tau and β-amyloid as biomarkers of cognitive dysfunction of Parkinson's disease. FASEB J 2021;35:e21895. [PMID: 34478572 DOI: 10.1096/fj.202100787R] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Chiaradia E, Miller I. In slow pace towards the proteome of equine body fluids. J Proteomics 2020;225:103880. [PMID: 32569818 DOI: 10.1016/j.jprot.2020.103880] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]